Ludwig Enterprises (LUDG) EBITDA Margin (2024)

Ludwig Enterprises' (LUDG) quarterly EBITDA Margin came in at 2124.22% in Q4 2024, up 101.24% on a QoQ basis from 171275.36% in Q3 2024.

Ludwig Enterprises (LUDG) EBITDA Margin (2024) Analysis & Trends

Ludwig Enterprises (LUDG) has 1 years of EBITDA Margin data on file, last reported at 2124.22% in Q4 2024.

Quarterly EBITDA Margin changed N/A year-over-year to 2124.22% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 598243.78% (changed N/A YoY) and the FY2024 annual result came in at 598243.78%, changed N/A from the prior year.
EBITDA Margin improved to 2124.22% in Q4 2024, from 171275.36% in the prior quarter.
In the past five years, EBITDA Margin ranged from a high of 2124.22% in Q4 2024 to a low of 3655790.0% in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn	13.44%
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn	25.18%
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn	19.10%
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn	21.65%
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn	29.48%
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn	24.33%
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn	13.96%
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn	10.30%
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn	19.15%
10	Ludwig Enterprises	1.67 Mn	1.67 Mn	-	-

Download Data